About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission

NCT02324439•Southern Illinois University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer

Interventions

Omega Nutrition cold-milled flaxseeds

Locations

1

United States

Locations (1)

Southern Illinois University School of Medicine

Springfield, Illinois, United States

Key Dates

Start Date

March 1, 2015

Primary Completion Date

March 1, 2020

Completion Date

March 1, 2021

Last Updated

April 1, 2022

Related Studies

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

NCT06710548

Ovarian CancerAdvanced Ovarian Carcinoma+5 more

RECRUITINGPhase 3

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025

Epithelial Ovarian CancerOvarian Cancer+2 more

RECRUITINGPhase 1

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

NCT02637934

Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

RECRUITINGEARLY Phase 1

Using Aspirin to Improve Immunological Features of Ovarian Tumors

NCT05080946

Ovarian CancerFallopian Tube Cancer+1 more

RECRUITINGPhase 1/2

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Advanced CancerMetastatic Cancer+7 more

RECRUITINGPhase 3

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian Cancer+5 more

View all related studies

Sponsors

Lead Sponsor

Southern Illinois University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 1, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions